DocDollars

Genetix Biotherapeutics Inc

MA · United States · Reporting entity ID 100001326930

Total reported 2019–2025
$12.4M
#435 of 2,960 reporting companies — 0% of all reported industry payments
$667K in general payments across 741 records, plus $11.7M in research funding across 469 records.

How it breaks down

General payments $666,958
Research funding $11,691,800

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Genetix Biotherapeutics Inc reported $12.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #435 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 741 general payment records and 469 research records were filed.

Common questions about Genetix Biotherapeutics Inc

How much has Genetix Biotherapeutics Inc paid US doctors?

Genetix Biotherapeutics Inc reported $12,358,758 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $666,958 in general payments, $11,691,800 in research funding.

How does Genetix Biotherapeutics Inc rank among drug and device companies?

It ranks #435 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Genetix Biotherapeutics Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.